Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes.

MLA

Genovese MC, et al. “Etanercept versus Methotrexate in Patients with Early Rheumatoid Arthritis: Two-Year Radiographic and Clinical Outcomes.” Arthritis & Rheumatism, vol. 46, no. 6, June 2002, pp. 1443–50. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=106972336&authtype=sso&custid=ns315887.

APA

Genovese MC, Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC, Wasko MC, Moreland LW, Weaver AL, Markenson J, Cannon GW, Spencer-Green G, & Finck BK. (2002). Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes. Arthritis & Rheumatism, 46(6), 1443–1450.

Chicago

Genovese MC, Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC, et al. 2002. “Etanercept versus Methotrexate in Patients with Early Rheumatoid Arthritis: Two-Year Radiographic and Clinical Outcomes.” Arthritis & Rheumatism 46 (6): 1443–50. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=106972336&authtype=sso&custid=ns315887.